RESEARCH FIELD Breaking Down Walls 06/25/2019 | Danny Ward To truly understand the intricacies of pathogenic bacteria, we need to combine “pure” and translational research. DISEASE AREA Tackling the Fatty-Liver Timebomb 06/28/2019 | Jonathan James Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease? RESEARCH FIELD Monitoring the Microbiome 03/25/2019 | Luke Turner Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer. DISEASE AREA Managing Malaria with Smarter Sampling 01/28/2019 | Jonathan James How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease. This email was sent to {~email~} by info@email.thetranslationalscientist.com. To ensure delivery of emails to your inbox, please add info@email.thetranslationalscientist.com to your address book or safe sender list. To view online, please click here. Create or manage your account here Unsubscribe here The Translational Scientist is a brand of Texere Publishing Limited Texere Publishing Limited, Booths Park 1, Chelford Road, Knutsford, WA16 8GS, UK Registered Company Number: 08113419 Texere Publishing Inc., 175 Varick Street, New York, NY 10014, USA Federal Identification Number: 81-4613586